Clinical Trial Update: A Study to Determine the Antitumor Activity and Evaluate the Safety of MKC-1 [Phase 2]

View source ↗

Summary

This is a Phase 2 clinical trial update assessing the antitumor activity and safety of MKC-1 in breast cancer; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• MKC-1

Snippet

Sponsor: CASI Pharmaceuticals, Inc. | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED